As part of the June issue,
European Respiratory Journal presents the latest in its series of podcasts. Hear Chief Editor Martin Kolb interview Kevin K. Brown (National Jewish Health, Denver, CO, USA) and Athol U. Wells (Royal Brompton Hospital, London, UK) about analyses of data from the INBUILD and INPULSIS trials, which suggest that progressive fibrosing interstitial lung diseases other than idiopathic pulmonary fibrosis (IPF) have a clinical course similar to IPF. Listen to the podcast
here or
read the full article.
No comments:
Post a Comment